Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - CLASS II - ANVISA Registration 10298910161

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - CLASS II in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10298910161 and manufactured by SUZHOU SYM-BIO LIFESCIENCE CO., LTD. The registration is held by REVVITY DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, RESPONSE BIOMEDICAL CORP., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10298910161
Registration Details
ANVISA Registration Number: 10298910161
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família SuperFlex N-terminal Pro-Brain Natriuretic Peptide
Risk Class II

Registration Details

10298910161

25351801508202110

00351210000124

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Aug 05, 2021

VIGENTE

09/18/2025 19:00:01